- Home
- FDBC vs IMMP Comparison
FDBC vs IMMP Comparison
Compare FDBC & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDBC
- IMMP
- Stock Information
- Founded
- FDBC 1902
- IMMP 1987
- Country
- FDBC United States
- IMMP Australia
- Employees
- FDBC N/A
- IMMP N/A
- Industry
- FDBC Major Banks
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- FDBC Finance
- IMMP Health Care
- Exchange
- FDBC Nasdaq
- IMMP Nasdaq
- Market Cap
- FDBC 226.2M
- IMMP 211.1M
- IPO Year
- FDBC N/A
- IMMP N/A
- Fundamental
- Price
- FDBC $40.34
- IMMP $1.85
- Analyst Decision
- FDBC
- IMMP Buy
- Analyst Count
- FDBC 0
- IMMP 2
- Target Price
- FDBC N/A
- IMMP $8.50
- AVG Volume (30 Days)
- FDBC 6.4K
- IMMP 647.3K
- Earning Date
- FDBC 04-23-2025
- IMMP 05-16-2025
- Dividend Yield
- FDBC 3.97%
- IMMP N/A
- EPS Growth
- FDBC 32.67
- IMMP N/A
- EPS
- FDBC 3.75
- IMMP N/A
- Revenue
- FDBC $81,621,000.00
- IMMP $3,019,249.00
- Revenue This Year
- FDBC N/A
- IMMP $11.25
- Revenue Next Year
- FDBC N/A
- IMMP $10.22
- P/E Ratio
- FDBC $10.76
- IMMP N/A
- Revenue Growth
- FDBC 15.50
- IMMP 24.11
- 52 Week Low
- FDBC $37.00
- IMMP $1.32
- 52 Week High
- FDBC $61.21
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- FDBC 48.15
- IMMP 53.09
- Support Level
- FDBC $40.54
- IMMP $1.44
- Resistance Level
- FDBC $41.50
- IMMP $2.71
- Average True Range (ATR)
- FDBC 1.20
- IMMP 0.18
- MACD
- FDBC 0.29
- IMMP 0.03
- Stochastic Oscillator
- FDBC 50.09
- IMMP 28.93
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.